Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis

被引:78
作者
Mead, RJ
Neal, JW
Griffiths, MR
Linington, C
Botto, M
Lassmann, H
Morgan, BP
机构
[1] Univ Wales Coll Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Wales Coll Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales
[3] Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany
[4] Hammersmith Hosp, Royal Postgrad Med Sch, Dept Med, Dept Rheumatol Unit, London, England
[5] Univ Vienna, Brain Res Inst, Div Neuroimmunol, Vienna, Austria
关键词
complement; CD59; knockout; demyelination; encephalomyelitis;
D O I
10.1038/labinvest.3700015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There is a growing body of evidence implicating complement and, in particular, the terminal pathway ( membrane attack complex; MAC) in inducing demyelination in multiple sclerosis and experimental allergic encephalomyelitis. In this paper, we examined the disease course and pathological changes in mice deficient in the major regulator of MAC assembly, CD59a, during the course of acute experimental allergic encephalomyelitis induced by immunisation with recombinant myelin oligodendrocyte glycoprotein. Disease incidence and severity were significantly increased in CD59a-deficient mice. The extent of inflammation, demyelination and axonal injury were assessed in spinal cord cross-sections from CD59a- deficient and control mice, and all these parameters were enhanced in the absence of CD59a. Areas of myelin loss and axonal damage in CD59a-deficient mice were associated with deposits of MAC, firmly implicating MAC as a cause of the observed injury. These findings are relevant to some types of human demyelination, where abundant deposits of MAC are found in association with pathology.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 48 条
  • [1] The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
    Adelmann, M
    Wood, J
    Benzel, I
    Fiori, P
    Lassmann, H
    Matthieu, JM
    Gardinier, MV
    Dornmair, K
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1995, 63 (01) : 17 - 27
  • [2] BORNSTEIN MB, 1965, ANN NY ACAD SCI, V122, P280
  • [3] Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice
    Bourquin, C
    Schubart, A
    Tobollik, S
    Mather, I
    Ogg, S
    Liblau, R
    Linington, C
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (01) : 455 - 461
  • [4] Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
    Calida, DM
    Constantinescu, C
    Purev, E
    Zhang, GX
    Ventura, ES
    Lavi, E
    Rostami, A
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (02) : 723 - 726
  • [5] The regional distribution of myelin oligodendrocyte glycoprotein (MOG) in the developing rat CNS: An in vivo immunohistochemical study
    Coffey, JC
    McDermott, KW
    [J]. JOURNAL OF NEUROCYTOLOGY, 1997, 26 (03): : 149 - 161
  • [6] IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE-SCLEROSIS
    COMPSTON, DAS
    MORGAN, BP
    CAMPBELL, AK
    WILKINS, P
    COLE, G
    THOMAS, ND
    JASANI, B
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1989, 15 (04) : 307 - 316
  • [7] Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
    Davie, CA
    Barker, GJ
    Webb, S
    Tofts, PS
    Thompson, AJ
    Harding, AE
    McDonald, WI
    Miller, DH
    [J]. BRAIN, 1995, 118 : 1583 - 1592
  • [8] Treatment with anti-interferon-γ monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-γ receptor knockout mice
    Espejo, C
    Penkowa, D
    Sáez-Torres, I
    Xaus, J
    Celada, A
    Montalban, X
    Martínez-Cáceres, EM
    [J]. EXPERIMENTAL NEUROLOGY, 2001, 172 (02) : 460 - 468
  • [9] Identification of autoantibodies associated with myelin damage in multiple sclerosis
    Genain, CP
    Cannella, B
    Hauser, SL
    Raine, CS
    [J]. NATURE MEDICINE, 1999, 5 (02) : 170 - 175
  • [10] Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison
    Harris, CL
    Hanna, SM
    Mizuno, M
    Holt, DS
    Marchbank, KJ
    Morgan, BP
    [J]. IMMUNOLOGY, 2003, 109 (01) : 117 - 126